Investing in skin cancer prevention in Australia could both save lives and significantly reduce the nation’s $2 billion (approx US$1.45 billion) a year in treatment costs, experts say.
In a new health economics paper published on Dec. 22 in Public Health Research & Practice, a peer-reviewed journal of the Sax Institute, the authors noted the enormous financial burden of treating skin cancers in Australia, despite the majority of these cancers being preventable and curable.
